Important safety considerations include: Increased hypoglycaemia risk when used with insulin or sulfonylureas (dose adjustments of these medications may be needed) Potential worsening of diabetic retinopathy with rapid improvement in blood glucose control, particularly with semaglutide Need for monitoring in patients with pre-existing retinopathy The MHRA continues to monitor the safety profile of these agents
The foam takes 5 to 10 minutes to settle, and during that time the peptide is exposed to sustained air-liquid interface stress
If heart rate increases remain problematic despite these measures, your physician may consider additional evaluation (such as ECG, electrolyte testing, or thyroid function tests), dose reduction, temporary treatment interruption, or discontinuation if clinically indicated
Are there other clinical trials of GLP-1 agonists in Parkinsons
This combination not only suppresses appetite but also promotes calorie burning, which makes it a multi-pathway approach to weight management